FDAFDA · Food and drugs·Recall number D-0450-2022
Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Published February 2, 2022 · Recall initiated: December 29, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent and Failed Tablet/Capsule Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- PIOGLITAZONE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide in the US
- UPC
- 0357237221303
- Lot
- Batch # PF4520028B & PF4520028A, Exp. Date 11/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.